BPR1K871

BPR1K871 is a potent and selective dual FLT3/AURKA inhibitor with IC 50 s of 19 nM and 22 nM for FLT3 and AURKA, respectively. BPR1K871 is a preclinical development candidate for anti-cancer therapy [1].

Price Not Available 25 mg BPR1K871 Supplier Page

Catalog Number	T10592
Alternative Name(s)	DBPR114
Research Area	Angiogenesis\|\|\|Tyrosine Kinase/Adaptors
Molecular Formula	C25H28ClN7O2S
CAS#	2443767-35-7
SMILES	O=C(NC1=CC(Cl)=CC=C1)NC2=NC=C(S2)CCNC3=NC=NC4=C3C=CC(OCCCN(C)C)=C4
Size	25 mg
Supplier Page	https://www.targetmol.com/compound/BPR1K871
Additional Information	https://www.targetmol.com/datasheet/T10592